Chinook Therapeutics Inc Cvr (ADRO)
SG&A Expense Growth
0.45%
Quarterly · Period ending:
ADRO SG&A Expense Growth
Latest reported0.45%period ending
Latest reported0.45%period ending
ADRO Quarterly SG&A Growth (QoQ) (0.00% → 0.45%)
Latest values, visible window
High-resolution chart · PNG
ADRO sg&a expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 0.4459% | |
| 18.4161% | |
| -12.4574% | |
| 3.0155% | |
| 8.6464% | |
| -12.905% | |
| 1.8241% | |
| -1.485% | |
| 3.5547% | |
| -2.4247% | |
| 3.1632% | |
| 3.6266% | |
| 2.6488% | |
| -0.3448% | |
| 3.1143% | |
| -6.1882% | |
| -1.6516% | |
| -3.2399% | |
| 2.7209% | |
| 28.7493% | |
| 17.443% | |
| -5.2818% | |
| 0% | |
| 0% | |
| -7.2165% | |
| 54.1908% | |
| 0% |